US Patent 7282351 Prostatic growth factor

Patent 7282351 was granted and assigned to Human Genome Sciences on October, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 16 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 16 Sep, 2023

Edits made to:

Infobox (+3 properties)

Infobox

Patent Inventor Names

Craig A. Rosen0

Peter L. Hudson0

Wei-Wu He0

Edits on 1 Sep, 2023

"Add patent abstract"

Golden AI

edited on 1 Sep, 2023

Edits made to:

Article (+527 characters)

Article

Patent abstract

The present invention relates to human PGF polypeptides and DNA (RNA) encoding such polypeptides. Also provided is a procedure for producing such polypeptides by recombinant techniques, and antibodies and antagonist/inhibitors against such polypeptides. Also provided are methods of using such polypeptides therapeutically for treating prostate cancer, to promote tissue regeneration and to facilitate wound healing. Also provided is a diagnostic assay to detect prostate cancer and benign prostatic hyperplasia.

Edits on 26 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 26 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=072823510

Edits on 19 May, 2023

"Remove leading 0 from patent number"

Golden AI